These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

965 related articles for article (PubMed ID: 31006664)

  • 1. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
    Zou G; Wang R; Wang M
    Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.
    Sun Y; Yang B; Lin M; Yu H; Chen H; Zhang Z
    Cancer Biomark; 2019; 24(3):299-305. PubMed ID: 30829615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Lv ZC; Fan YS; Chen HB; Zhao DW
    Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced serum exosomal miR-874 expression predicts poor prognosis in colorectal cancer.
    Zhang N; Zhang PP; Huang JJ; Wang ZY; Zhang ZH; Yuan JZ; Ma EM; Liu X; Bai J
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):664-672. PubMed ID: 32016967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum
    Wang N; Zeng L; Li Z; Zhen Y; Chen H
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2650-2653. PubMed ID: 31240955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
    Yuan D; Li K; Zhu K; Yan R; Dang C
    Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
    Wang LL; Du LT; Li J; Liu YM; Qu AL; Yang YM; Zhang X; Zheng GX; Wang CX
    World J Gastroenterol; 2014 Aug; 20(32):11340-6. PubMed ID: 25170220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
    Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
    Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
    Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
    Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
    Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
    Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of serum miR-103 predicts unfavorable prognosis in patients with colorectal cancer.
    Wang DS; Zhong B; Zhang MS; Gao Y
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4518-4523. PubMed ID: 30058684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer.
    Yu H; Gao G; Jiang L; Guo L; Lin M; Jiao X; Jia W; Huang J
    Int J Clin Exp Pathol; 2013; 6(12):2904-11. PubMed ID: 24294377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum microRNA-135a-5p as an auxiliary diagnostic biomarker for colorectal cancer.
    Wang Q; Zhang H; Shen X; Ju S
    Ann Clin Biochem; 2017 Jan; 54(1):76-85. PubMed ID: 27126269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
    Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
    Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
    Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
    World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
    Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
    Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.
    Shi Y; Liu Z
    J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced serum miR-98 predicts unfavorable clinical outcome of colorectal cancer.
    Wang YG; He Q; Guo SQ; Shi ZZ
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8345-8353. PubMed ID: 31646564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
    Huang Y; Xiao W; Jiang X; Li H
    Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.